A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma

Show full item record



Permalink

http://hdl.handle.net/10138/164043

Citation

Schnitzbauer , A A , Zuelke , C , Graeb , C , Rochon , J , Bilbao , I , Burra , P , de Jong , K P , Duvoux , C , Kneteman , N M , Adam , R , Bechstein , W O , Becker , T , Beckebaum , S , Chazouilleres , O , Cillo , U , Colledan , M , Faendrich , F , Gugenheim , J , Hauss , J P , Heise , M , Hidalgo , E , Jamieson , N , Koenigsrainer , A , Lamby , P E , Lerut , J P , Mäkisalo , H , Margreiter , R , Mazzaferro , V , Mutzbauer , I , Otto , G , Pageaux , G-P , Pinna , A D , Pirenne , J , Rizell , M , Rossi , G , Rostaing , L , Roy , A , Sanchez Turrion , V , Schmidt , J , Troisi , R I , van Hoek , B , Valente , U , Wolf , P , Wolters , H , Mirza , D F , Scholz , T , Steininger , R , Soderdahl , G , Strasser , S I , Jauch , K-W , Neuhaus , P , Schlitt , H J & Geissler , E K 2010 , ' A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma ' , BMC Cancer , vol. 10 , pp. Article Number: 190 . https://doi.org/10.1186/1471-2407-10-190

Title: A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma
Author: Schnitzbauer, Andreas A.; Zuelke, Carl; Graeb, Christian; Rochon, Justine; Bilbao, Itxarone; Burra, Patrizia; de Jong, Koert P.; Duvoux, Christophe; Kneteman, Norman M.; Adam, Rene; Bechstein, Wolf O.; Becker, Thomas; Beckebaum, Susanne; Chazouilleres, Olivier; Cillo, Umberto; Colledan, Michele; Faendrich, Fred; Gugenheim, Jean; Hauss, Johann P.; Heise, Michael; Hidalgo, Ernest; Jamieson, Neville; Koenigsrainer, Alfred; Lamby, Philipp E.; Lerut, Jan P.; Mäkisalo, Heikki; Margreiter, Raimund; Mazzaferro, Vincenzo; Mutzbauer, Ingrid; Otto, Gerd; Pageaux, Georges-Philippe; Pinna, Antonio D.; Pirenne, Jacques; Rizell, Magnus; Rossi, Giorgio; Rostaing, Lionel; Roy, Andre; Sanchez Turrion, Victor; Schmidt, Jan; Troisi, Roberto I.; van Hoek, Bart; Valente, Umberto; Wolf, Philippe; Wolters, Heiner; Mirza, Darius F.; Scholz, Tim; Steininger, Rudolf; Soderdahl, Gunnar; Strasser, Simone I.; Jauch, Karl-Walter; Neuhaus, Peter; Schlitt, Hans J.; Geissler, Edward K.
Contributor organization: IV kirurgian klinikka
Date: 2010
Language: eng
Number of pages: 8
Belongs to series: BMC Cancer
ISSN: 1471-2407
DOI: https://doi.org/10.1186/1471-2407-10-190
URI: http://hdl.handle.net/10138/164043
Subject: ENDOTHELIAL GROWTH-FACTOR
RENAL-CELL CARCINOMA
TUMOR PROGRESSION
RAPAMYCIN
CANCER
CYCLOSPORINE
EFFICACY
THERAPY
TARGET
MODEL
312 Clinical medicine
Peer reviewed: Yes
Rights: cc_by
Usage restriction: openAccess
Self-archived version: publishedVersion


Files in this item

Total number of downloads: Loading...

Files Size Format View
1471_2407_10_190.pdf 570.1Kb PDF View/Open

This item appears in the following Collection(s)

Show full item record